Back to Search Start Over

Identification of Hub Genes Correlated with the Initiation and Development in Chronic Kidney Disease via Bioinformatics Analysis.

Authors :
Zhu, Kai
Li, Xinxin
Gao, Likun
Ji, Mengyao
Huang, Xu
Zhao, Yu
Diao, Wenxiu
Fan, Yanqin
Chen, Xinghua
Luo, Pengcheng
Shen, Lei
Li, Lili
Source :
Kidney & Blood Pressure Research. 2023, Vol. 48 Issue 1, p79-91. 13p.
Publication Year :
2023

Abstract

Introduction: Chronic kidney disease (CKD) is a major public health issue worldwide, which is characterized by irreversible loss of nephron and renal function. However, the molecular mechanism of CKD remains underexplored. Methods: This study integrated three transcriptional profile datasets to investigate the molecular mechanism of CKD. The differentially expressed genes (DEGs) between Sham control (Con) and unilateral ureteral obstruction (UUO)-operated mice were analyzed by utilizing the limma package in R. The shared DEGs were analyzed by Gene Ontology and functional enrichment. Protein-protein interactions (PPIs) were constructed by utilizing the STRING database. Hub genes were analyzed by MCODE and Cytohubba. We further validated the gene expression by using the other dataset and mouse UUO model. Results: A total of 315 shared DEGs between Con and UUO samples were identified. Gene function and KEGG pathway enrichment revealed that DEGs were mainly enriched in inflammatory response, immune system process, and chemokine signaling pathway. Two modules were clustered based on PPI network analysis. Module 1 contained 13 genes related to macrophage activation, migration, and chemotaxis. Ten hub genes were identified by PPI network analysis. Subsequently, the expression levels of hub genes were validated with the other dataset. Finally, these four validated hub genes were further confirmed by our UUO mice. Three validated hub genes, Gng2, Pf4, and Ccl9, showed significant response to UUO. Conclusion: Our study reveals the coordination of genes during UUO and provides a promising gene panel for CKD treatment. GNG2 and PF4 were identified as potential targets for developing CKD drugs. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14204096
Volume :
48
Issue :
1
Database :
Academic Search Index
Journal :
Kidney & Blood Pressure Research
Publication Type :
Academic Journal
Accession number :
174424725
Full Text :
https://doi.org/10.1159/000528870